• 3X (DYKDDDDK) Peptide: Structural Precision for Affinity Pur

  2026-05-07

  Explore how the 3X (DYKDDDDK) Peptide enables high-fidelity affinity purification of FLAG-tagged proteins. Delve into the structural, mechanistic, and assay-specific factors that elevate its performance beyond conventional tags.

• Minoxidil Sulphate in Renal Vasculature: Research Protocols

  2026-05-06

  Explore Minoxidil sulphate as a pivotal tool in vascular biology and renal blood flow research. This article uniquely focuses on its application in dissecting potassium channel function in the renal vasculature, offering advanced protocols and a critical analysis of translational impacts.

• Spermine Tetrahydrochloride: Precision Crosslinking & Protei

  2026-05-06

  Spermine tetrahydrochloride empowers researchers to stabilize protoplasts, enhance protein crystallization, and crosslink polyphosphazene nanoparticles with unmatched reproducibility. Leveraging data-driven protocols and troubleshooting insights, this article translates bench-top experimental workflows into reliable results across cell biology, protein biochemistry, and nanoparticle engineering.

• Salinomycin as a Polyether Ionophore: Mechanistic Insights f

  2026-05-05

  Explore how Salinomycin, a polyether ionophore antibiotic, advances hepatocellular carcinoma research with unique mechanistic insights and actionable protocols. This article goes beyond existing resources by dissecting ion transport, toxicity, and translational assay decisions for precision cancer modeling.

• NSAID Cytotoxicity in Canine Osteosarcoma: Insights for Bone

  2026-05-05

  This study systematically compared the in vitro cytotoxic effects of deracoxib and piroxicam on canine osteosarcoma cell lines, revealing that deracoxib achieved cytotoxicity at lower concentrations than piroxicam and selectively spared fibroblasts. These findings refine our understanding of NSAID utility as antiproliferative agents in tumor cell lines and inform preclinical assay design for bone metabolism and oncology research.

• METTL14 Modulates Colitis via m6A and the DHRS4-AS1/miR-206/

  2026-05-04

  This study elucidates how METTL14-mediated m6A modification regulates inflammation in ulcerative colitis through the DHRS4-AS1/miR-206/A3AR axis. The findings reveal a critical epigenetic mechanism underlying colonic inflammatory injury, offering new targets for therapeutic intervention and experimental design in methylation-dependent disease models.

• 8-Chloroadenosine: Mechanistic Insights for lncRNA and RNA D

  2026-05-04

  Explore the advanced utility of 8-Chloroadenosine as a nucleoside analog in dissecting lncRNA-mediated transcriptional regulation and RNA metabolism. This in-depth guide uniquely connects molecular mechanism with high-impact cancer research workflows.

• nPEC: A Universal Method for Dual-Loaded Liposome Efficiency

  2026-05-03

  This study establishes nanoparticle exclusion HPLC (nPEC) as a universally applicable and accurate method for determining encapsulation efficiency in dual-loaded liposomes, even when hydrophilic and lipophilic drugs differ significantly in their properties. These findings streamline combinatorial drug delivery research and have immediate implications for optimizing antiviral and immune modulation studies.

• Dibutyryl-cAMP, Sodium Salt: Mechanisms and Benchmarks in cA

  2026-05-02

  Dibutyryl-cAMP, sodium salt is a cell-permeable, stable cyclic AMP analog that selectively activates cAMP-dependent signaling, notably protein kinase A. This article details its mechanism, evidentiary support, and optimal workflow parameters for robust cAMP signaling pathway research.

• Capsaicin in Research: Protocol Enhancements and Troubleshoo

  2026-05-02

  Capsaicin ((E)-Capsaicin) is a dual-action research tool that enables precise modulation of TRPV1 ion channels and epigenetic targets. This article delivers stepwise protocols, advanced applications, and actionable troubleshooting insights for maximizing reproducibility in pain, inflammation, and cancer models.

• BV6: Selective IAP Antagonist for Cancer and Endometriosis R

  2026-05-01

  BV6 is a selective IAP antagonist that induces apoptosis in cancer cells and sensitizes them to chemotherapy and radiotherapy. It exhibits a verified IC50 of 7.2 μM in H460 NSCLC cells and reduces cIAP1 and XIAP levels in multiple cell models. Its robust solubility in DMSO and ethanol and validated in vivo activity make it a key research tool for apoptosis and endometriosis studies.

• Berberrubine Modulates Metabolism and Gut Microbiota in NAFL

  2026-04-30

  This article examines the 2022 study by Yang et al., which identified berberrubine—a primary metabolite of berberine—as a potent modulator of glucose and lipid metabolism and gut microbiota in non-alcoholic fatty liver disease (NAFLD) models. The findings highlight berberrubine’s multifaceted mechanism of action and its translational value for metabolic disease research.

• β-Amanitin: Precision Tools for RNA Polymerase II Studies

  2026-04-30

  β-Amanitin unlocks high-specificity inhibition of RNA polymerase II, enabling precise dissection of transcriptional regulation and gene expression workflows. Learn how to optimize experimental protocols and troubleshoot common challenges using APExBIO’s research-grade β-Amanitin for advanced transcriptional and toxicology studies.

• Hoechst 33342: Transforming Nuclear Staining in Cell Biology

  2026-04-29

  Hoechst 33342, a benchmark bis-benzimidazole fluorescent dye, empowers researchers with high-specificity nuclear visualization for live-cell assays and advanced disease models. Thanks to APExBIO’s high-purity supply, workflows from cell cycle analysis to apoptosis detection become more reproducible, quantitative, and interpretable.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Me

  2026-04-29

  Xiao et al. (2024) uncover a lysosomal 25-hydroxycholesterol (25HC)–AMPK axis that metabolically reprograms tumor-associated macrophages (TAMs) toward immunosuppression. By detailing how CH25H-derived 25HC activates AMPKα and STAT6 signaling, the study presents a mechanistic basis for targeting macrophage metabolism to enhance anti-tumor immunity.

436 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page